Study report: Proficiency testing study on a WHO/TAL-trained methodology.
- Published in:
- WHO Drug Information, 2020, v. 34, n. 4, p. 809
- Publication type:
- Article
Works matching IS 10109609 AND DT 2020 AND VI 34 AND IP 4
Results: 10
1
2
RIFAMPICIN.
- Published in:
- WHO Drug Information, 2020, v. 34, n. 4, p. 843
- Publication type:
- Article
3
OXYGEN.
- Published in:
- WHO Drug Information, 2020, v. 34, n. 4, p. 907
- Publication type:
- Article
4
REMDESIVIR INTRAVENOUS INFUSION.
- Published in:
- WHO Drug Information, 2020, v. 34, n. 4, p. 871
- Publication type:
- Article
5
Study report: Proficiency testing study on a WHO/TAL-trained methodology.
- Published in:
- WHO Drug Information, 2020, v. 34, n. 4, p. 899
- Publication type:
- Article
6
White Paper for the WHO International Meeting of World Pharmacopoeias: Value of Pharmacopoeial Standards for Access to Quality Medicines.
- Published in:
- WHO Drug Information, 2020, v. 34, n. 4, p. 802
- Publication type:
- Article
7
WHO GUIDELINES ON THE TRANSFER OF TECHNOLOGY IN PHARMACEUTICAL MANUFACTURING.
- Published in:
- WHO Drug Information, 2020, v. 34, n. 4, p. 877
- Publication type:
- Article
8
DOLUTEGRAVIR TABLETS.
- Published in:
- WHO Drug Information, 2020, v. 34, n. 4, p. 857
- Publication type:
- Article
9
DOLUTEGRAVIR SODIUM.
- Published in:
- WHO Drug Information, 2020, v. 34, n. 4, p. 846
- Publication type:
- Article
10
International Nonproprietary Names for Pharmaceutical Substances (INN).
- Published in:
- WHO Drug Information, 2020, v. 34, n. 4, p. 929
- Publication type:
- Article